MSD - China HIV/AIDS Partnership (C-MAP)

Partnership objective

Increase awareness of HIV/AIDS, and strengthen prevention, treatment and support for those affected in the country.

The Chinese government has committed to achieving goals for the control of critical diseases such as hepatitis B, HIV/AIDS, and NCDs in its 12th Five-Year Plan. The Chinese government has committed to achieving goals for the control of critical diseases such as hepatitis B, HIV/AIDS, and NCDs in its 12th Five-Year Plan. Copyright MSD

What are the health needs and challenges?

China has significantly strengthened its capacity for prevention and control of infectious diseases during the past decade. However, some epidemics such as viral hepatitis and HIV/AIDS remain critical health challenges. Meanwhile, an aging population and changing lifestyles have led to a surging burden of non-communicable chronic diseases (NCDs), especially cancer, diabetes and cardiovascular disease. The Chinese government has committed to achieving goals for the control of critical diseases such as hepatitis B, HIV/AIDS, and NCDs in its 12th Five-Year Plan. It is investing in expanding the coverage and provisions of a universal insurance system to reduce the financial burden of healthcare for all Chinese citizens; strengthening primary care services to improve availability and quality of diagnosis, treatment and care; and expanding public awareness and prevention measures.

Description of partnership activities and how they address needs and challenges

In 2005, the Merck (MSD*) Foundation and the Government of China established the first large-scale comprehensive public/private partnership known as the China-MSD HIV/AIDS Partnership (C-MAP), to address HIV and AIDS prevention, patient care, treatment and support, in support of "China's Action Plan for Reducing & Preventing the spread of HIV/AIDS, 2006-2010." The partners introduced the program in Liangshan Prefecture, Sichuan Province, with the aim of developing a model that could be replicated in other provinces.

The Merck Foundation committed USD $30 million over eight years (2005-2012) to support this partnership.. The Government of China, through its Ministry of Health, is providing staff, facilities and equipment. C-MAP has project offices in three places: in Beijing; in Chengdu, the capital of Sichuan province; and in Sichuan Province’s Liangshan Prefecture.

C-MAP is focused on six goals:

  • Raising awareness and reducing discrimination among target populations through training and education;
  • Deploying comprehensive, integrated risk-reduction approaches to reduce HIV transmission among high-risk populations;
  • Establishing a service network to provide consecutive treatment, care and support to people living with HIV/AIDS;
  • Providing support to orphans and families affected by HIV to alleviate negative social and economic impacts;
  • Building capacity of health care workers and organizations and developing new anti-HIV strategies and techniques;
  • Strengthening HIV surveillance, monitoring and evaluation systems and data management and analysis to track program implementation assess program outcomes, and identify and apply best practices in a timely manner.

C-MAP collaborates with approximately 11,500 people working in 1,600 implementing organizations, including departments within the government of China, medical and health institutions, civil societies, international organizations, grassroots healthcare workers, and beneficiary groups.

In October 2013, the Merck Foundation committed an addidtional $6 million over three years (2014-2016) to support a second phase of C-MAP to strengthen integrated HIV treatment capacity and cooperation between the township and county health systems of Liangshan Prefecture, and to expand the program to new sites in Chongqing municipality and Fujian Province to improve HIV/AIDS management and treatment services. During this next phase, C-MAP aims to further improve treatment coverage by strengthening the capacity of healthcare workers to support the implementation of effective patient referrals and promote quality HIV treatment through health worker training in HIV diagnosis, treatment and  disease management.

Summary of impact and forward looking information

C-MAP was the first large-scale public-private partnership between the Chinese government and a private multinational company focusing on HIV/AIDS prevention, treatment and control.

Since 2007, in addition to raising awareness, the partnership has successfully established an overall HIV prevention and treatment network in Liangshan.This, coupled with training, has helped improve the capacity of local healthcare providers, expand antiretroviral treatment (ART) coverage, and created a replicable model for HIV prevention and control in other ethnic-minority areas. The collaboration brought new technologies to strengthen the testing capabilities of local labs, provided necessary lab equipment and medical supplies, and developed healthcare services specifically targeted to pregnant women to help prevent mother-to-child transmission.

In 2011, the China-MSD HIV/AIDS Partnership received China's most prestigious award in the charity field, the China Charity Award — Most Influential Charity Program, which distinguishes significant contributions to public welfare and charity work in China.

Key Indicators and Achievements from 2007-2012

  • 8 million people have received face-to-face HIV education
  • 14 million people have received HIV information through mass-media educational programs
  • 262,000 at-risk individuals have undergone targeted HIV-prevention interventions
  • 214 provider-initiated HIV-testing and counseling sites have been established in 17 counties
  • 5,546 people living with AIDS have received anti-retroviral treatment
  • 4,181 people living with AIDS have been provided support and care
  • 60,000 healthcare workers have been trained
  • 599 public health workers have been hired to address staff shortages at local health facilities
  • 641,000 people have been tested for HIV


*MSD is known as Merck in the U.S. and Canada.


HIV/AIDS- Unwavering Committment

Partnership information

Company(ies) MSD

Partner(s) Chinese Ministry of Health

Type of Partner(s) Government

Therapeutic Focus Infectious Diseases

Disease(s) HIV/AIDS

Program Type(s) Health System Infrastructure - Outreach & Medical Services, Health System Infrastructure - Training, Prevention Programs - Awareness & Outreach

Targeted Population(s) Men, Patients in needs of treatment, Women, Youth

Region(s) East Asia & Pacific

Number of Countries 1

Country(ies) China

Start Date 2005

More information C-MAP Initiative

Anticipated completion date Ongoing

« The C-MAP program, co-implemented by MSD and the government, has provided a new model form AIDS prevention and control. The model — and lessons learned — have ensured the... program is sustainable. »

Zhongfu Liu, Deputy Director, National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention